ELEVANCE HEALTH, INC. Selling Expense
ELEVANCE HEALTH, INC. (ELV) reported Selling Expense of $330.00 million for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-10-31.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingExpense · last filed 2018-10-31
- ELEVANCE HEALTH, INC. selling expense for the quarter ending 2018-09-30 was $330.00M, a 5.17% decline year-over-year.
- ELEVANCE HEALTH, INC. selling expense for the quarter ending 2018-06-30 was $323.60M, a 6.34% decline year-over-year.
- ELEVANCE HEALTH, INC. selling expense for the quarter ending 2018-03-31 was $318.20M, a 8.72% decline year-over-year.
- ELEVANCE HEALTH, INC. selling expense for the quarter ending 2017-12-31 was $353.50M, a 0.54% increase year-over-year.
- ELEVANCE HEALTH, INC. selling expense for fiscal 2017 was $1.40B, a 0.29% increase from fiscal 2016.
- ELEVANCE HEALTH, INC. selling expense for fiscal 2016 was $1.39B, a 3.44% decline from fiscal 2015.
- ELEVANCE HEALTH, INC. selling expense for fiscal 2015 was $1.44B, a 3.29% decline from fiscal 2014.
- ELEVANCE HEALTH, INC. selling expense for fiscal 2014 was $1.49B, a 2.41% decline from fiscal 2013.
| Period end | Selling Expense 3 month | Selling Expense 3 month as first filed | Selling Expense 6 month | Selling Expense 9 month | Selling Expense 12 month |
|---|---|---|---|---|---|
| 2018-09-30 | $330.00M 10-Q · filed 2018-10-31 | $653.60M derived: sum of 2 quarters · filed 2018-10-31 | $972.00M 10-Q · filed 2018-10-31 | $1.33B derived: sum of 4 quarters · filed 2018-10-31 | |
| 2018-06-30 | $323.60M 10-Q · filed 2018-07-25 | $641.80M 10-Q · filed 2018-07-25 | $995.30M derived: sum of 3 quarters · filed 2018-07-25 | $1.34B derived: sum of 4 quarters · filed 2018-10-31 | |
| 2018-03-31 | $318.20M 10-Q · filed 2018-04-25 | $671.70M derived: sum of 2 quarters · filed 2018-04-25 | $1.02B derived: sum of 3 quarters · filed 2018-10-31 | $1.37B derived: sum of 4 quarters · filed 2018-10-31 | |
| 2017-12-31 | $353.50M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $701.50M derived: sum of 2 quarters · filed 2018-10-31 | $1.05B derived: sum of 3 quarters · filed 2018-10-31 | $1.40B 10-K · filed 2018-02-21 | |
| 2017-09-30 | $348.00M 10-Q · filed 2018-10-31 | $347.90M 10-Q · filed 2017-10-25 | $693.50M derived: sum of 2 quarters · filed 2018-10-31 | $1.04B 10-Q · filed 2018-10-31 | $1.39B derived: sum of 4 quarters · filed 2018-10-31 |
| 2017-06-30 | $345.50M 10-Q · filed 2018-07-25 | $694.10M 10-Q · filed 2018-07-25 | $1.05B derived: sum of 3 quarters · filed 2018-07-25 | $1.38B derived: sum of 4 quarters · filed 2018-07-25 | |
| 2017-03-31 | $348.60M 10-Q · filed 2018-04-25 | $700.20M derived: sum of 2 quarters · filed 2018-04-25 | $1.04B derived: sum of 3 quarters · filed 2018-04-25 | $1.39B derived: sum of 4 quarters · filed 2018-04-25 | |
| 2016-12-31 | $351.60M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $690.10M derived: sum of 2 quarters · filed 2018-02-21 | $1.04B derived: sum of 3 quarters · filed 2018-02-21 | $1.39B 10-K · filed 2018-02-21 | |
| 2016-09-30 | $338.50M 10-Q · filed 2017-10-25 | $690.00M derived: sum of 2 quarters · filed 2017-10-25 | $1.04B 10-Q · filed 2017-10-25 | $1.39B derived: sum of 4 quarters · filed 2018-02-21 | |
| 2016-06-30 | $351.50M 10-Q · filed 2017-07-26 | $701.40M 10-Q · filed 2017-07-26 | $1.05B derived: sum of 3 quarters · filed 2018-02-21 | $1.41B derived: sum of 4 quarters · filed 2018-02-21 | |
| 2016-03-31 | $349.90M 10-Q · filed 2017-04-26 | $699.90M derived: sum of 2 quarters · filed 2018-02-21 | $1.06B derived: sum of 3 quarters · filed 2018-02-21 | $1.42B derived: sum of 4 quarters · filed 2018-02-21 | |
| 2015-12-31 | $350.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $709.10M derived: sum of 2 quarters · filed 2018-02-21 | $1.07B derived: sum of 3 quarters · filed 2018-02-21 | $1.44B 10-K · filed 2018-02-21 | |
| 2015-09-30 | $359.10M 10-Q · filed 2016-11-02 | $722.90M derived: sum of 2 quarters · filed 2016-11-02 | $1.09B 10-Q · filed 2016-11-02 | $1.45B derived: sum of 4 quarters · filed 2017-02-22 | |
| 2015-06-30 | $363.80M 10-Q · filed 2016-07-27 | $732.00M 10-Q · filed 2016-07-27 | $1.09B derived: sum of 3 quarters · filed 2017-02-22 | $1.46B derived: sum of 4 quarters · filed 2017-02-22 | |
| 2015-03-31 | $368.20M 10-Q · filed 2016-04-27 | $724.50M derived: sum of 2 quarters · filed 2017-02-22 | $1.10B derived: sum of 3 quarters · filed 2017-02-22 | $1.49B derived: sum of 4 quarters · filed 2017-02-22 | |
| 2014-12-31 | $356.30M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $730.60M derived: sum of 2 quarters · filed 2017-02-22 | $1.12B derived: sum of 3 quarters · filed 2017-02-22 | $1.49B 10-K · filed 2017-02-22 | |
| 2014-09-30 | $374.30M 10-Q · filed 2015-10-28 | $763.00M derived: sum of 2 quarters · filed 2015-10-28 | $1.13B 10-Q · filed 2015-10-28 | $1.52B derived: sum of 4 quarters · filed 2016-02-19 | |
| 2014-06-30 | $388.70M 10-Q · filed 2015-07-29 | $759.50M 10-Q · filed 2015-07-29 | $1.15B derived: sum of 3 quarters · filed 2016-02-19 | $1.52B derived: sum of 4 quarters · filed 2016-02-19 | |
| 2014-03-31 | $370.80M 10-Q · filed 2015-04-29 | $757.80M derived: sum of 2 quarters · filed 2016-02-19 | $1.14B derived: sum of 3 quarters · filed 2016-02-19 | $1.51B derived: sum of 4 quarters · filed 2016-02-19 | |
| 2013-12-31 | $387.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $764.30M derived: sum of 2 quarters · filed 2016-02-19 | $1.14B derived: sum of 3 quarters · filed 2016-02-19 | $1.53B 10-K · filed 2016-02-19 | |
| 2013-09-30 | $377.30M 10-Q · filed 2014-10-29 | $754.00M derived: sum of 2 quarters · filed 2014-10-29 | $1.14B 10-Q · filed 2014-10-29 | $1.55B derived: sum of 4 quarters · filed 2015-02-24 | |
| 2013-06-30 | $376.70M 10-Q · filed 2014-07-30 | $762.60M 10-Q · filed 2013-07-24 | $1.17B derived: sum of 3 quarters · filed 2015-02-24 | $1.56B derived: sum of 4 quarters · filed 2015-02-24 | |
| 2013-03-31 | $385.90M 10-Q · filed 2014-04-30 | $796.30M derived: sum of 2 quarters · filed 2015-02-24 | $1.19B derived: sum of 3 quarters · filed 2015-02-24 | $1.58B derived: sum of 4 quarters · filed 2015-02-24 | |
| 2012-12-31 | $410.40M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $800.60M derived: sum of 2 quarters · filed 2015-02-24 | $1.19B derived: sum of 3 quarters · filed 2015-02-24 | $1.59B 10-K · filed 2015-02-24 | |
| 2012-09-30 | $390.20M 10-Q · filed 2013-10-23 | $783.20M derived: sum of 2 quarters · filed 2013-10-23 | $1.18B 10-Q · filed 2013-10-23 | $1.59B derived: sum of 4 quarters · filed 2014-02-20 | |
| 2012-06-30 | $393.00M 10-Q · filed 2013-07-24 | $786.30M 10-Q · filed 2013-07-24 | $1.20B derived: sum of 3 quarters · filed 2014-02-20 | $1.60B derived: sum of 4 quarters · filed 2014-02-20 | |
| 2012-03-31 | $393.30M 10-Q · filed 2013-04-24 | $804.50M derived: sum of 2 quarters · filed 2014-02-20 | $1.21B derived: sum of 3 quarters · filed 2014-02-20 | $1.61B derived: sum of 4 quarters · filed 2014-02-20 | |
| 2011-12-31 | $411.20M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | $814.20M derived: sum of 2 quarters · filed 2014-02-20 | $1.22B derived: sum of 3 quarters · filed 2014-02-20 | $1.62B 10-K · filed 2014-02-20 | |
| 2011-09-30 | $403.00M 10-Q · filed 2012-11-07 | $808.60M derived: sum of 2 quarters · filed 2012-11-07 | $1.21B 10-Q · filed 2012-11-07 | $1.61B derived: sum of 4 quarters · filed 2013-02-22 | |
| 2011-06-30 | $405.60M 10-Q · filed 2012-07-25 | $802.60M 10-Q · filed 2012-07-25 | $1.21B derived: sum of 3 quarters · filed 2013-02-22 | $1.61B derived: sum of 4 quarters · filed 2013-02-22 | |
| 2011-03-31 | $397.00M 10-Q · filed 2012-04-25 | $801.10M derived: sum of 2 quarters · filed 2013-02-22 | $1.20B derived: sum of 3 quarters · filed 2013-02-22 | $1.60B derived: sum of 4 quarters · filed 2013-02-22 | |
| 2010-12-31 | $404.10M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22 | $804.80M derived: sum of 2 quarters · filed 2013-02-22 | $1.21B derived: sum of 3 quarters · filed 2013-02-22 | $1.61B 10-K · filed 2013-02-22 | |
| 2010-09-30 | $400.70M 10-Q · filed 2011-10-26 | $803.80M derived: sum of 2 quarters · filed 2011-10-26 | $1.21B 10-Q · filed 2011-10-26 | $1.62B derived: sum of 4 quarters · filed 2012-02-22 | |
| 2010-06-30 | $403.10M 10-Q · filed 2011-07-27 | $805.50M 10-Q · filed 2011-07-27 | $1.22B derived: sum of 3 quarters · filed 2012-02-22 | $1.64B derived: sum of 4 quarters · filed 2012-02-22 | |
| 2010-03-31 | $402.40M 10-Q · filed 2011-04-27 | $814.10M derived: sum of 2 quarters · filed 2012-02-22 | $1.23B derived: sum of 3 quarters · filed 2012-02-22 | $1.66B derived: sum of 4 quarters · filed 2012-02-22 | |
| 2009-12-31 | $411.70M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $832.30M derived: sum of 2 quarters · filed 2012-02-22 | $1.25B derived: sum of 3 quarters · filed 2012-02-22 | $1.69B 10-K · filed 2012-02-22 | |
| 2009-09-30 | $420.60M 10-Q · filed 2010-11-03 | $841.80M derived: sum of 2 quarters · filed 2010-11-03 | $1.27B 10-Q · filed 2010-11-03 | $1.71B derived: sum of 4 quarters · filed 2011-02-17 | |
| 2009-06-30 | $421.20M 10-Q/A · filed 2010-08-03 | $853.20M 10-Q/A · filed 2010-08-03 | $1.29B derived: sum of 3 quarters · filed 2011-02-17 | $1.74B derived: sum of 4 quarters · filed 2011-02-17 | |
| 2009-03-31 | $432.00M 10-Q · filed 2010-04-28 | $872.80M derived: sum of 2 quarters · filed 2011-02-17 | $1.32B derived: sum of 3 quarters · filed 2011-02-17 | $1.77B derived: sum of 4 quarters · filed 2011-02-17 | |
| 2008-12-31 | $440.80M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-17 | $889.00M derived: sum of 2 quarters · filed 2011-02-17 | $1.33B derived: sum of 3 quarters · filed 2011-02-17 | $1.78B 10-K · filed 2011-02-17 | |
| 2008-09-30 | $448.20M 10-Q · filed 2009-10-28 | $893.30M derived: sum of 2 quarters · filed 2009-10-28 | $1.34B 10-Q · filed 2009-10-28 | ||
| 2008-06-30 | $445.10M 10-Q · filed 2009-07-29 | $889.40M 10-Q · filed 2009-07-29 | |||
| 2007-12-31 | $1.72B 10-K · filed 2010-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |